| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.787 | 0.003 | 0.822 | Estrogen antagonist | 0.813 0.003 CID_3036172 0.822 0.003 CID_10090750 0.284 0.007 CID_10474509 | CID_10090750 | |
| 0.767 | 0.016 | 0.8 | Caspase 9 stimulant | 0.779 0.014 CID_3036172 0.8 0.011 CID_10090750 0.499 0.06 CID_10474509 | CID_10090750 | |
| 0.652 | 0.004 | 0.652 | Growth factor agonist | 0.587 0.004 CID_3036172 0.55 0.004 CID_10090750 0.307 0.014 CID_10474509 | ||
| 0.648 | 0.005 | 0.651 | Vasodilator, coronary | 0.625 0.007 CID_3036172 0.651 0.005 CID_10090750 0.636 0.006 CID_10474509 | CID_10090750 | |
| 0.551 | 0.009 | 0.569 | Vasodilator | 0.569 0.007 CID_3036172 0.535 0.009 CID_10090750 0.394 0.024 CID_10474509 | CID_3036172 | |
| 0.539 | 0.027 | 0.672 | Aldehyde oxidase inhibitor | 0.618 0.017 CID_3036172 0.672 0.01 CID_10090750 0.632 0.015 CID_10474509 | CID_10090750 | |
| 0.529 | 0.018 | 0.545 | Calcium channel L-type activator | 0.545 0.014 CID_10090750 0.523 0.02 CID_10474509 | CID_10090750 | |
| 0.525 | 0.02 | 0.596 | Spasmolytic | 0.383 0.044 CID_3036172 0.578 0.015 CID_10090750 0.596 0.013 CID_10474509 | CID_10474509 | |
| 0.474 | 0.005 | 0.48 | Anesthetic local | 0.302 0.012 CID_3036172 0.431 0.005 CID_10090750 0.48 0.005 CID_10474509 | CID_10474509 | |
| 0.468 | 0.001 | 0.735 | Estrogen-related receptor gamma agonist | 0.086 0.002 CID_3036172 0.735 0.001 CID_10090750 0.057 0.002 CID_10474509 | CID_10090750 | |
| 0.492 | 0.029 | 0.572 | 5 Hydroxytryptamine release stimulant | 0.572 0.017 CID_3036172 0.506 0.026 CID_10090750 0.542 0.021 CID_10474509 | CID_3036172 | |
| 0.435 | 0.021 | 0.49 | DNA damaging | 0.49 0.015 CID_3036172 0.45 0.019 CID_10090750 0.234 0.09 CID_10474509 | CID_3036172 | |
| 0.415 | 0.004 | 0.499 | Estrogen agonist | 0.455 0.004 CID_3036172 0.499 0.004 CID_10090750 0.084 0.022 CID_10474509 | CID_10090750 | |
| 0.41 | 0.001 | 0.469 | Estrogen-related receptor beta antagonist | 0.469 0.001 CID_3036172 0.383 0.001 CID_10090750 0.181 0.002 CID_10474509 | CID_3036172 | |
| 0.414 | 0.005 | 0.414 | Alpha 2b adrenoreceptor antagonist | 0.304 0.009 CID_3036172 0.354 0.006 CID_10090750 0.125 0.055 CID_10474509 | ||
| 0.428 | 0.036 | 0.445 | Caspase 3 stimulant | 0.44 0.032 CID_3036172 0.445 0.031 CID_10090750 0.214 0.149 CID_10474509 | CID_10090750 | |
| 0.36 | 0.004 | 0.485 | Estrogen receptor beta antagonist | 0.399 0.004 CID_3036172 0.485 0.004 CID_10090750 0.124 0.028 CID_10474509 | CID_10090750 | |
| 0.363 | 0.029 | 0.363 | Psychostimulant | 0.236 0.064 CID_3036172 0.361 0.029 CID_10090750 0.327 0.036 CID_10474509 | ||
| 0.337 | 0.004 | 0.337 | 5 Hydroxytryptamine 3E antagonist | 0.317 0.004 CID_3036172 0.266 0.01 CID_10090750 0.266 0.01 CID_10474509 | ||
| 0.363 | 0.042 | 0.363 | Calcium channel activator | 0.36 0.044 CID_3036172 0.344 0.054 CID_10090750 0.362 0.042 CID_10474509 | ||
| 0.323 | 0.003 | 0.323 | Histamine H2 receptor antagonist | 0.218 0.005 CID_3036172 0.226 0.005 CID_10090750 0.117 0.022 CID_10474509 | ||
| 0.308 | 0.001 | 0.432 | Estrogen-related receptor beta agonist | 0.258 0.002 CID_3036172 0.432 0.001 CID_10090750 0.174 0.003 CID_10474509 | CID_10090750 | |
| 0.365 | 0.078 | 0.402 | GABA C receptor rho-3 antagonist | 0.399 0.062 CID_3036172 0.402 0.06 CID_10090750 | CID_10090750 | |
| 0.289 | 0.003 | 0.366 | Beta 3 adrenoreceptor antagonist | 0.165 0.005 CID_3036172 0.366 0.002 CID_10090750 0.267 0.003 CID_10474509 | CID_10090750 | |
| 0.303 | 0.028 | 0.303 | P-glycoprotein inhibitor | 0.295 0.03 CID_3036172 0.281 0.033 CID_10090750 0.214 0.056 CID_10474509 | ||
| 0.275 | 0.004 | 0.367 | CYP2A6 inhibitor | 0.367 0.003 CID_3036172 0.21 0.006 CID_10090750 0.131 0.022 CID_10474509 | CID_3036172 | |
| 0.382 | 0.123 | 0.432 | Apoptosis agonist | 0.359 0.134 CID_3036172 0.432 0.099 CID_10090750 | CID_10090750 | |
| 0.278 | 0.019 | 0.283 | Acetylcholine M1 receptor antagonist | 0.239 0.028 CID_3036172 0.283 0.018 CID_10090750 0.159 0.066 CID_10474509 | CID_10090750 | |
| 0.239 | 0.004 | 0.319 | Toll-Like receptor 3 antagonist | 0.319 0.003 CID_3036172 0.18 0.008 CID_10090750 0.174 0.009 CID_10474509 | CID_3036172 | |
| 0.306 | 0.074 | 0.345 | Sodium/bile acid cotransporter inhibitor | 0.234 0.146 CID_3036172 0.345 0.043 CID_10090750 0.322 0.06 CID_10474509 | CID_10090750 | |
| 0.235 | 0.005 | 0.284 | Phosphodiesterase 4A inhibitor | 0.284 0.005 CID_3036172 0.166 0.009 CID_10090750 | CID_3036172 | |
| 0.219 | 0.007 | 0.219 | Sphingomyelinase inhibitor | 0.218 0.007 CID_3036172 0.192 0.011 CID_10090750 0.218 0.007 CID_10474509 | ||
| 0.244 | 0.038 | 0.311 | Insulin sensitizer | 0.246 0.037 CID_3036172 0.255 0.032 CID_10090750 0.311 0.014 CID_10474509 | CID_10474509 | |
| 0.299 | 0.092 | 0.383 | Cholesterol antagonist | 0.275 0.108 CID_3036172 0.346 0.066 CID_10090750 0.383 0.053 CID_10474509 | CID_10474509 | |
| 0.244 | 0.045 | 0.244 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.22 0.057 CID_3036172 0.221 0.057 CID_10090750 | ||
| 0.246 | 0.053 | 0.28 | Peptidyltransferase inhibitor | 0.232 0.065 CID_3036172 0.268 0.039 CID_10090750 0.28 0.033 CID_10474509 | CID_10474509 | |
| 0.292 | 0.101 | 0.405 | Vasodilator, peripheral | 0.298 0.098 CID_10090750 0.405 0.053 CID_10474509 | CID_10474509 | |
| 0.216 | 0.029 | 0.22 | Nav1.2 sodium channel blocker | 0.177 0.044 CID_3036172 0.173 0.045 CID_10090750 0.22 0.028 CID_10474509 | CID_10474509 | |
| 0.189 | 0.004 | 0.23 | Beta 1 adrenoreceptor antagonist | 0.124 0.007 CID_3036172 0.23 0.003 CID_10090750 0.192 0.004 CID_10474509 | CID_10090750 | |
| 0.196 | 0.014 | 0.196 | Alpha 2a adrenoreceptor antagonist | 0.166 0.019 CID_3036172 0.176 0.018 CID_10090750 | ||
| 0.185 | 0.01 | 0.203 | Thioredoxin inhibitor | 0.203 0.008 CID_3036172 0.182 0.01 CID_10090750 | CID_3036172 | |
| 0.245 | 0.073 | 0.303 | Tyrosine 3 hydroxylase inhibitor | 0.303 0.032 CID_3036172 0.295 0.035 CID_10090750 0.185 0.165 CID_10474509 | CID_3036172 | |
| 0.179 | 0.007 | 0.179 | Adrenaline uptake inhibitor | 0.139 0.011 CID_10090750 0.123 0.014 CID_10474509 | ||
| 0.318 | 0.147 | 0.377 | Cyclophilin D inhibitor | 0.377 0.104 CID_3036172 0.34 0.129 CID_10090750 | CID_3036172 | |
| 0.189 | 0.019 | 0.189 | Alpha 2 adrenoreceptor antagonist | 0.13 0.033 CID_3036172 0.151 0.027 CID_10090750 | ||
| 0.172 | 0.005 | 0.216 | Beta adrenoreceptor antagonist | 0.137 0.007 CID_3036172 0.216 0.004 CID_10090750 0.195 0.004 CID_10474509 | CID_10090750 | |
| 0.174 | 0.009 | 0.374 | Estrogen receptor alpha antagonist | 0.153 0.011 CID_3036172 0.374 0.004 CID_10090750 0.081 0.047 CID_10474509 | CID_10090750 | |
| 0.197 | 0.035 | 0.21 | Cyclooxygenase 1 inhibitor | 0.206 0.032 CID_3036172 0.21 0.03 CID_10090750 | CID_10090750 | |
| 0.174 | 0.013 | 0.174 | 5 Hydroxytryptamine uptake inhibitor | 0.103 0.025 CID_10090750 0.083 0.033 CID_10474509 | ||
| 0.331 | 0.173 | 0.331 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.275 0.248 CID_3036172 | ||
| 0.197 | 0.043 | 0.224 | Cyclooxygenase inhibitor | 0.224 0.033 CID_3036172 0.197 0.043 CID_10090750 | CID_3036172 | |
| 0.18 | 0.028 | 0.18 | Nav1.6 sodium channel blocker | 0.147 0.057 CID_3036172 0.149 0.055 CID_10090750 0.162 0.042 CID_10474509 | ||
| 0.183 | 0.031 | 0.21 | Nav1.3 sodium channel blocker | 0.101 0.096 CID_3036172 0.135 0.06 CID_10090750 0.21 0.021 CID_10474509 | CID_10474509 | |
| 0.153 | 0.003 | 0.153 | Phospholipase D inhibitor | 0.12 0.006 CID_3036172 0.146 0.004 CID_10090750 0.11 0.01 CID_10474509 | ||
| 0.177 | 0.033 | 0.183 | Proteasome inhibitor | 0.183 0.031 CID_3036172 0.174 0.034 CID_10090750 0.098 0.089 CID_10474509 | CID_3036172 | |
| 0.168 | 0.025 | 0.168 | Alpha 2c adrenoreceptor antagonist | 0.129 0.043 CID_3036172 0.144 0.035 CID_10090750 | ||
| 0.157 | 0.015 | 0.166 | Anabolic | 0.166 0.011 CID_3036172 0.166 0.011 CID_10090750 0.123 0.037 CID_10474509 | CID_10090750 | |
| 0.172 | 0.033 | 0.19 | Adenylate cyclase stimulant | 0.153 0.058 CID_3036172 0.19 0.019 CID_10090750 0.178 0.027 CID_10474509 | CID_10090750 | |
| 0.142 | 0.004 | 0.154 | Estrogen-related receptor alpha antagonist | 0.154 0.004 CID_3036172 0.141 0.004 CID_10090750 0.042 0.016 CID_10474509 | CID_3036172 | |
| 0.137 | 0.001 | 0.253 | Estrogen-related receptor gamma antagonist | 0.088 0.001 CID_3036172 0.253 0.001 CID_10090750 0.074 0.002 CID_10474509 | CID_10090750 | |
| 0.153 | 0.017 | 0.219 | Phosphodiesterase I inhibitor | 0.219 0.009 CID_3036172 0.13 0.023 CID_10090750 | CID_3036172 | |
| 0.14 | 0.004 | 0.14 | 5 Hydroxytryptamine 1B agonist | 0.12 0.005 CID_3036172 0.102 0.006 CID_10090750 0.097 0.007 CID_10474509 | ||
| 0.14 | 0.005 | 0.16 | Phosphodiesterase 1C inhibitor | 0.16 0.004 CID_3036172 0.121 0.006 CID_10090750 | CID_3036172 | |
| 0.177 | 0.043 | 0.232 | Bone formation stimulant | 0.232 0.028 CID_3036172 0.21 0.033 CID_10090750 0.129 0.077 CID_10474509 | CID_3036172 | |
| 0.162 | 0.028 | 0.177 | Vanilloid 1 agonist | 0.155 0.033 CID_3036172 0.177 0.02 CID_10090750 0.145 0.043 CID_10474509 | CID_10090750 | |
| 0.229 | 0.105 | 0.302 | 5 Hydroxytryptamine uptake stimulant | 0.302 0.044 CID_3036172 0.218 0.12 CID_10090750 | CID_3036172 | |
| 0.13 | 0.006 | 0.13 | Phosphodiesterase 1A inhibitor | 0.126 0.006 CID_3036172 0.088 0.013 CID_10090750 | ||
| 0.132 | 0.009 | 0.156 | Phosphodiesterase 1B inhibitor | 0.156 0.006 CID_3036172 0.104 0.013 CID_10090750 | CID_3036172 | |
| 0.17 | 0.05 | 0.175 | GABA C receptor rho-2 antagonist | 0.134 0.098 CID_3036172 0.175 0.046 CID_10090750 | CID_10090750 | |
| 0.131 | 0.017 | 0.131 | Alpha 1d adrenoreceptor antagonist | 0.085 0.028 CID_3036172 0.086 0.028 CID_10090750 0.051 0.048 CID_10474509 | ||
| 0.192 | 0.079 | 0.226 | Anesthetic general | 0.212 0.068 CID_3036172 0.226 0.061 CID_10090750 0.176 0.09 CID_10474509 | CID_10090750 | |
| 0.123 | 0.012 | 0.123 | Acetylcholine M5 receptor antagonist | 0.086 0.022 CID_3036172 0.107 0.016 CID_10090750 | ||
| 0.136 | 0.028 | 0.136 | Acetylcholine release stimulant | 0.117 0.053 CID_3036172 0.108 0.069 CID_10090750 0.101 0.085 CID_10474509 | ||
| 0.121 | 0.014 | 0.121 | Dopamine uptake inhibitor | 0.071 0.03 CID_3036172 0.092 0.021 CID_10090750 0.054 0.044 CID_10474509 | ||
| 0.142 | 0.038 | 0.173 | Antiadrenergic | 0.08 0.071 CID_3036172 0.119 0.046 CID_10090750 0.173 0.03 CID_10474509 | CID_10474509 | |
| 0.154 | 0.05 | 0.154 | Cholinergic antagonist | 0.123 0.071 CID_3036172 0.151 0.052 CID_10090750 | ||
| 0.284 | 0.184 | 0.398 | 5 Hydroxytryptamine release inhibitor | 0.398 0.079 CID_3036172 0.297 0.168 CID_10090750 0.329 0.135 CID_10474509 | CID_3036172 | |
| 0.146 | 0.046 | 0.152 | Acetylcholine muscarinic antagonist | 0.117 0.07 CID_3036172 0.152 0.043 CID_10090750 | CID_10090750 | |
| 0.137 | 0.038 | 0.169 | Adrenaline antagonist | 0.077 0.071 CID_3036172 0.115 0.046 CID_10090750 0.169 0.03 CID_10474509 | CID_10474509 | |
| 0.147 | 0.051 | 0.147 | Acetylcholine antagonist | 0.115 0.075 CID_3036172 0.144 0.053 CID_10090750 | ||
| 0.135 | 0.048 | 0.135 | 5 Hydroxytryptamine 2B antagonist | 0.121 0.06 CID_3036172 0.102 0.081 CID_10090750 | ||
| 0.107 | 0.023 | 0.107 | Acetylcholine M4 receptor antagonist | 0.088 0.039 CID_3036172 0.072 0.054 CID_10090750 | ||
| 0.142 | 0.06 | 0.177 | Cyclooxygenase 2 inhibitor | 0.177 0.039 CID_3036172 0.138 0.063 CID_10090750 | CID_3036172 | |
| 0.115 | 0.036 | 0.115 | Glutamate (mGluR7) agonist | 0.091 0.082 CID_3036172 0.09 0.084 CID_10474509 | ||
| 0.085 | 0.008 | 0.085 | Squalene epoxidase inhibitor | 0.072 0.013 CID_3036172 0.083 0.009 CID_10090750 0.061 0.019 CID_10474509 | ||
| 0.098 | 0.025 | 0.15 | Dopamine D1 antagonist | 0.067 0.042 CID_3036172 0.15 0.015 CID_10090750 | CID_10090750 | |
| 0.099 | 0.027 | 0.099 | Adenosine A3 receptor antagonist | 0.085 0.037 CID_3036172 0.091 0.031 CID_10090750 | ||
| 0.167 | 0.095 | 0.167 | MAP kinase kinase 5 inhibitor | 0.154 0.135 CID_3036172 0.151 0.147 CID_10090750 0.154 0.136 CID_10474509 | ||
| 0.105 | 0.039 | 0.127 | Ornithine decarboxylase inhibitor | 0.127 0.021 CID_3036172 0.112 0.032 CID_10090750 0.081 0.066 CID_10474509 | CID_3036172 | |
| 0.104 | 0.043 | 0.104 | 5 Hydroxytryptamine 2C antagonist | 0.08 0.061 CID_3036172 | ||
| 0.105 | 0.044 | 0.123 | Calcium antagonist | 0.123 0.033 CID_3036172 0.112 0.04 CID_10474509 | CID_3036172 | |
| 0.215 | 0.155 | 0.292 | Transcription factor NF kappa B inhibitor | 0.216 0.154 CID_3036172 0.292 0.099 CID_10090750 0.214 0.155 CID_10474509 | CID_10090750 | |
| 0.109 | 0.052 | 0.109 | Alpha adrenoreceptor antagonist | 0.08 0.071 CID_10090750 | ||
| 0.073 | 0.016 | 0.077 | Thromboxane synthase inhibitor | 0.077 0.013 CID_3036172 0.073 0.015 CID_10090750 | CID_3036172 | |
| 0.096 | 0.039 | 0.165 | Adrenaline agonist | 0.145 0.016 CID_10090750 0.165 0.011 CID_10474509 | CID_10474509 | |
| 0.194 | 0.138 | 0.194 | 5 Hydroxytryptamine 1E antagonist | 0.174 0.161 CID_10090750 | ||
| 0.074 | 0.019 | 0.074 | Glycine transporter inhibitor | 0.044 0.037 CID_3036172 0.061 0.024 CID_10474509 | ||
| 0.059 | 0.006 | 0.065 | Dopamine autoreceptor agonist | 0.038 0.01 CID_3036172 0.065 0.005 CID_10090750 | CID_10090750 | |
| 0.07 | 0.017 | 0.1 | Beta 2 adrenoreceptor antagonist | 0.058 0.026 CID_3036172 0.09 0.009 CID_10090750 0.1 0.008 CID_10474509 | CID_10474509 | |
| 0.091 | 0.04 | 0.091 | Alpha 1a adrenoreceptor antagonist | |||
| 0.094 | 0.045 | 0.094 | Alpha 1 adrenoreceptor antagonist | |||
| 0.099 | 0.051 | 0.099 | ABCA1 expression enhancer | 0.09 0.065 CID_3036172 0.099 0.051 CID_10090750 | ||
| 0.076 | 0.028 | 0.094 | Acetylcholine M3 receptor antagonist | 0.06 0.041 CID_3036172 0.094 0.02 CID_10090750 | CID_10090750 | |
| 0.178 | 0.133 | 0.236 | Nitric-oxide synthase stimulant | 0.195 0.098 CID_3036172 0.192 0.104 CID_10090750 0.236 0.043 CID_10474509 | CID_10474509 | |
| 0.075 | 0.033 | 0.075 | Acetylcholine M2 receptor antagonist | 0.054 0.05 CID_3036172 0.071 0.036 CID_10090750 | ||
| 0.056 | 0.016 | 0.119 | Estrogen receptor alpha agonist | 0.062 0.015 CID_3036172 0.119 0.007 CID_10090750 | CID_10090750 | |
| 0.053 | 0.013 | 0.059 | Diamine oxidase inhibitor | 0.059 0.01 CID_3036172 0.034 0.032 CID_10090750 0.034 0.031 CID_10474509 | CID_3036172 | |
| 0.118 | 0.08 | 0.15 | Cyclooxygenase 3 inhibitor | 0.15 0.048 CID_3036172 0.129 0.068 CID_10090750 0.12 0.078 CID_10474509 | CID_3036172 | |
| 0.046 | 0.009 | 0.046 | Melatonin receptor 1A agonist | 0.035 0.021 CID_3036172 | ||
| 0.097 | 0.066 | 0.127 | GABA C receptor rho-1 antagonist | 0.127 0.034 CID_3036172 0.098 0.064 CID_10090750 0.091 0.076 CID_10474509 | CID_3036172 | |
| 0.045 | 0.015 | 0.045 | Delayed rectifier potassium channel blocker | 0.041 0.02 CID_3036172 0.036 0.028 CID_10090750 | ||
| 0.058 | 0.028 | 0.058 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.109 | 0.079 | 0.129 | Alkylator | 0.125 0.063 CID_10090750 0.129 0.06 CID_10474509 | CID_10474509 | |
| 0.09 | 0.061 | 0.099 | Glutamate release inhibitor | 0.097 0.048 CID_3036172 0.099 0.044 CID_10474509 | CID_10474509 | |
| 0.065 | 0.038 | 0.175 | Aromatase inhibitor | 0.175 0.01 CID_3036172 0.074 0.031 CID_10090750 | CID_3036172 | |
| 0.066 | 0.039 | 0.074 | Nitric oxide donor | 0.074 0.028 CID_3036172 0.06 0.048 CID_10090750 0.062 0.046 CID_10474509 | CID_3036172 | |
| 0.102 | 0.075 | 0.191 | GABA C receptor antagonist | 0.191 0.015 CID_3036172 0.112 0.062 CID_10090750 | CID_3036172 | |
| 0.042 | 0.019 | 0.042 | Glycine transporter 1 inhibitor | 0.036 0.024 CID_10474509 | ||
| 0.211 | 0.189 | 0.326 | Histamine release inhibitor | 0.235 0.167 CID_3036172 0.269 0.142 CID_10090750 0.326 0.111 CID_10474509 | CID_10474509 | |
| 0.056 | 0.035 | 0.066 | Epithelial sodium channel blocker | 0.066 0.021 CID_3036172 0.051 0.046 CID_10090750 0.05 0.048 CID_10474509 | CID_3036172 | |
| 0.077 | 0.058 | 0.077 | Acetylcholine nicotinic antagonist | |||
| 0.083 | 0.064 | 0.116 | Histamine N-methyltransferase inhibitor | 0.116 0.033 CID_3036172 0.078 0.069 CID_10090750 | CID_3036172 | |
| 0.068 | 0.051 | 0.088 | Peroxisome proliferator-activated receptor gamma agonist | 0.061 0.057 CID_3036172 0.063 0.055 CID_10090750 0.088 0.035 CID_10474509 | CID_10474509 | |
| 0.023 | 0.006 | 0.027 | Antibiotic Anthracycline-like | 0.026 0.005 CID_3036172 0.027 0.004 CID_10090750 0.021 0.009 CID_10474509 | CID_10090750 | |
| 0.118 | 0.101 | 0.135 | Sphingosine 1-phosphate receptor 2 antagonist | 0.135 0.065 CID_3036172 0.114 0.113 CID_10090750 | CID_3036172 | |
| 0.093 | 0.077 | 0.093 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.089 | 0.072 | 0.116 | MAO A inhibitor | 0.099 0.065 CID_3036172 0.116 0.054 CID_10090750 | CID_10090750 | |
| 0.186 | 0.171 | 0.186 | Gastrin inhibitor | 0.182 0.176 CID_10474509 | ||
| 0.04 | 0.025 | 0.065 | GABA uptake inhibitor | 0.065 0.008 CID_3036172 0.037 0.03 CID_10090750 0.04 0.027 CID_10474509 | CID_3036172 | |
| 0.06 | 0.045 | 0.06 | Dopamine D3 antagonist | |||
| 0.101 | 0.089 | 0.158 | MAO inhibitor | 0.158 0.057 CID_3036172 0.125 0.072 CID_10090750 | CID_3036172 | |
| 0.084 | 0.072 | 0.084 | Antihistaminic | |||
| 0.062 | 0.051 | 0.062 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.168 | 0.158 | 0.354 | Superoxide dismutase inhibitor | 0.354 0.036 CID_3036172 0.202 0.116 CID_10090750 | CID_3036172 | |
| 0.11 | 0.099 | 0.11 | Calcium channel blocker | |||
| 0.089 | 0.079 | 0.089 | Gastric antisecretory | |||
| 0.053 | 0.044 | 0.053 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.066 | 0.057 | 0.066 | Calcium channel L-type blocker | |||
| 0.157 | 0.149 | 0.247 | Immunostimulant | 0.247 0.097 CID_3036172 0.207 0.116 CID_10090750 0.182 0.132 CID_10474509 | CID_3036172 | |
| 0.066 | 0.057 | 0.066 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.14 | 0.132 | 0.19 | Succinate dehydrogenase inhibitor | 0.19 0.058 CID_3036172 0.147 0.118 CID_10090750 0.138 0.137 CID_10474509 | CID_3036172 | |
| 0.048 | 0.041 | 0.048 | Alpha 1b adrenoreceptor agonist | |||
| 0.098 | 0.091 | 0.124 | Cholesterol synthesis inhibitor | 0.108 0.077 CID_3036172 0.12 0.065 CID_10090750 0.124 0.062 CID_10474509 | CID_10474509 | |
| 0.034 | 0.027 | 0.039 | Kainate receptor 2 antagonist | 0.039 0.023 CID_3036172 | CID_3036172 | |
| 0.08 | 0.075 | 0.098 | Granulocyte macrophage colony stimulating factor agonist | 0.098 0.037 CID_3036172 | CID_3036172 | |
| 0.074 | 0.068 | 0.1 | Phosphodiesterase IV inhibitor | 0.1 0.045 CID_3036172 | CID_3036172 | |
| 0.071 | 0.066 | 0.071 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.059 | 0.054 | 0.068 | Beta 2 adrenoreceptor agonist | 0.059 0.056 CID_3036172 0.068 0.023 CID_10090750 0.064 0.034 CID_10474509 | CID_10090750 | |
| 0.075 | 0.07 | 0.075 | Histamine antagonist | |||
| 0.041 | 0.037 | 0.041 | Histamine H1 receptor agonist | |||
| 0.129 | 0.126 | 0.139 | Ca2+-transporting ATPase inhibitor | 0.139 0.075 CID_3036172 0.132 0.111 CID_10090750 | CID_3036172 | |
| 0.059 | 0.056 | 0.059 | Neuronal nicotinic receptor antagonist | |||
| 0.043 | 0.04 | 0.055 | Beta adrenoreceptor agonist | 0.051 0.015 CID_10090750 0.055 0.011 CID_10474509 | CID_10474509 | |
| 0.087 | 0.084 | 0.087 | Nitric-oxide synthase inhibitor | |||
| 0.124 | 0.121 | 0.145 | Arachidonic acid antagonist | 0.145 0.094 CID_3036172 0.131 0.112 CID_10090750 | CID_3036172 | |
| 0.078 | 0.076 | 0.113 | Vanilloid agonist | 0.113 0.022 CID_3036172 0.09 0.047 CID_10090750 | CID_3036172 | |
| 0.024 | 0.022 | 0.024 | Acid ceramidase inhibitor | |||
| 0.08 | 0.08 | 0.108 | Prolactin inhibitor | 0.087 0.071 CID_3036172 0.108 0.048 CID_10090750 | CID_10090750 | |
| 0.042 | 0.044 | 0.052 | Plasminogen activator inhibitor antagonist | 0.052 0.031 CID_3036172 0.047 0.036 CID_10090750 | CID_3036172 | |
| 0.028 | 0.031 | 0.04 | Retinoid X receptor agonist | 0.04 0.022 CID_3036172 | CID_3036172 | |
| 0.035 | 0.038 | 0.047 | Oxytocin agonist | 0.047 0.026 CID_10090750 | CID_10090750 | |
| 0.051 | 0.054 | 0.058 | Immunoglobulin Fc receptor antagonist | 0.058 0.029 CID_10474509 | CID_10474509 | |
| 0.044 | 0.05 | 0.059 | Acyl-CoA dehydrogenase inhibitor | 0.059 0.034 CID_3036172 0.057 0.035 CID_10474509 | CID_3036172 | |
| 0.051 | 0.057 | 0.089 | 5 Hydroxytryptamine 2A agonist | 0.089 0.02 CID_3036172 | CID_3036172 | |
| 0.093 | 0.101 | 0.105 | TRPA1 agonist | 0.105 0.079 CID_10090750 | CID_10090750 | |
| 0.187 | 0.195 | 0.266 | Antithrombotic | 0.266 0.114 CID_3036172 0.206 0.17 CID_10090750 0.236 0.138 CID_10474509 | CID_3036172 | |
| 0.043 | 0.052 | 0.058 | Cytokine production stimulant | 0.058 0.014 CID_3036172 | CID_3036172 | |
| 0.097 | 0.106 | 0.21 | Alpha-N-acetylglucosaminidase inhibitor | 0.105 0.095 CID_3036172 0.21 0.031 CID_10474509 | CID_10474509 | |
| 0.02 | 0.029 | 0.024 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 CID_10474509 | CID_10474509 | |
| 0.042 | 0.051 | 0.049 | Lysophosphatidic acid 3 receptor antagonist | 0.049 0.037 CID_3036172 | CID_3036172 | |
| 0.067 | 0.078 | 0.082 | Interferon agonist | 0.082 0.049 CID_3036172 0.073 0.064 CID_10474509 | CID_3036172 | |
| 0.07 | 0.081 | 0.095 | Glutathione S-transferase inhibitor | 0.095 0.042 CID_3036172 | CID_3036172 | |
| 0.025 | 0.037 | 0.032 | Peroxisome proliferator-activated receptor delta agonist | 0.032 0.025 CID_10474509 | CID_10474509 | |
| 0.096 | 0.112 | 0.138 | Toll-Like receptor 2 antagonist | 0.125 0.073 CID_3036172 0.138 0.061 CID_10090750 0.112 0.087 CID_10474509 | CID_10090750 | |
| 0.025 | 0.041 | 0.031 | Retinoid X alpha receptor agonist | 0.031 0.03 CID_3036172 | CID_3036172 | |
| 0.017 | 0.033 | 0.028 | Beta 1 adrenoreceptor agonist | 0.023 0.015 CID_10090750 0.028 0.009 CID_10474509 | CID_10474509 | |
| 0.044 | 0.06 | 0.051 | Leukotriene B4 antagonist | 0.051 0.042 CID_3036172 0.05 0.044 CID_10090750 | CID_3036172 | |
| 0.053 | 0.069 | 0.061 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.05 CID_3036172 | CID_3036172 | |
| 0.034 | 0.051 | 0.039 | Geranyltranstransferase inhibitor | 0.039 0.038 CID_3036172 | CID_3036172 | |
| 0.138 | 0.156 | 0.181 | Neurotrophic factor enhancer | 0.181 0.097 CID_10090750 | CID_10090750 | |
| 0.031 | 0.05 | 0.053 | Sphingosine 1-phosphate receptor 1 agonist | 0.042 0.03 CID_3036172 0.053 0.017 CID_10474509 | CID_10474509 | |
| 0.066 | 0.089 | 0.128 | MAO B inhibitor | 0.128 0.047 CID_3036172 0.082 0.074 CID_10090750 | CID_3036172 | |
| 0.03 | 0.053 | 0.041 | Glycine transporter 2 inhibitor | 0.04 0.039 CID_3036172 0.041 0.038 CID_10090750 | CID_10090750 | |
| 0.051 | 0.074 | 0.138 | Phenylalanine 4-hydroxylase inhibitor | 0.076 0.04 CID_3036172 0.08 0.037 CID_10090750 0.138 0.014 CID_10474509 | CID_10474509 | |
| 0.043 | 0.067 | 0.049 | Vanilloid 2 antagonist | 0.049 0.043 CID_10090750 | CID_10090750 | |
| 0.091 | 0.116 | 0.125 | Aldehyde dehydrogenase inhibitor | 0.12 0.071 CID_3036172 0.125 0.066 CID_10090750 0.115 0.077 CID_10474509 | CID_10090750 | |
| 0.075 | 0.102 | 0.1 | Lanosterol 14 alpha demethylase inhibitor | 0.1 0.055 CID_3036172 | CID_3036172 | |
| 0.06 | 0.086 | 0.067 | Peroxisome proliferator-activated receptor gamma antagonist | 0.067 0.061 CID_10474509 | CID_10474509 | |
| 0.089 | 0.115 | 0.104 | Photosensitizer | 0.104 0.081 CID_3036172 | CID_3036172 | |
| 0.13 | 0.16 | 0.151 | Neurotensin receptor agonist | 0.142 0.123 CID_3036172 0.151 0.1 CID_10090750 | CID_10090750 | |
| 0.046 | 0.077 | 0.062 | Sphingosine 1-phosphate receptor 4 agonist | 0.062 0.052 CID_3036172 | CID_3036172 | |
| 0.136 | 0.167 | 0.251 | Free radical scavenger | 0.251 0.068 CID_10090750 | CID_10090750 | |
| 0.014 | 0.047 | 0.03 | Uridine phosphorylase inhibitor | 0.03 0.018 CID_3036172 | CID_3036172 | |
| 0.02 | 0.053 | 0.028 | Retinoid X gamma receptor antagonist | 0.028 0.017 CID_3036172 | CID_3036172 | |
| 0.142 | 0.176 | 0.255 | Antioxidant | 0.164 0.148 CID_3036172 0.255 0.081 CID_10090750 | CID_10090750 | |
| 0.061 | 0.096 | 0.088 | Opioid kappa receptor antagonist | 0.088 0.047 CID_10090750 | CID_10090750 | |
| 0.062 | 0.097 | 0.084 | Myeloperoxidase inhibitor | 0.084 0.059 CID_3036172 0.076 0.075 CID_10090750 | CID_3036172 | |
| 0.05 | 0.087 | 0.061 | Interferon inducer | 0.061 0.051 CID_3036172 | CID_3036172 | |
| 0.095 | 0.132 | 0.121 | Protein kinase stimulant | 0.111 0.103 CID_3036172 0.121 0.092 CID_10090750 | CID_10090750 | |
| 0.055 | 0.092 | 0.076 | Exportin-1 inhibitor | 0.076 0.031 CID_3036172 | CID_3036172 | |
| 0.04 | 0.078 | 0.059 | Sphingosine kinase 2 inhibitor | 0.059 0.033 CID_3036172 | CID_3036172 | |
| 0.025 | 0.065 | 0.056 | Dopamine D5 agonist | 0.056 0.014 CID_3036172 0.039 0.029 CID_10090750 | CID_3036172 | |
| 0.17 | 0.21 | 0.213 | Insulysin inhibitor | 0.213 0.139 CID_3036172 0.193 0.167 CID_10090750 | CID_3036172 | |
| 0.01 | 0.051 | 0.074 | Estrogen receptor beta agonist | 0.074 0.015 CID_10090750 | CID_10090750 | |
| 0.057 | 0.1 | 0.077 | Androgen antagonist | 0.077 0.069 CID_10090750 | CID_10090750 | |
| 0.028 | 0.073 | 0.047 | Sphingosine 1-phosphate receptor agonist | 0.047 0.027 CID_10474509 | CID_10474509 | |
| 0.066 | 0.114 | 0.116 | Creatine kinase inhibitor | 0.116 0.044 CID_3036172 0.112 0.047 CID_10090750 | CID_3036172 | |
| 0.023 | 0.072 | 0.032 | Retinoid X alpha receptor antagonist | 0.032 0.028 CID_3036172 | CID_3036172 | |
| 0.013 | 0.063 | 0.02 | Retinoid X beta receptor antagonist | 0.02 0.016 CID_3036172 | CID_3036172 | |
| 0.014 | 0.065 | 0.057 | Leukotriene A4 hydrolase inhibitor | 0.057 0.017 CID_3036172 | CID_3036172 | |
| 0.121 | 0.172 | 0.176 | Hypolipemic | 0.176 0.112 CID_10474509 | CID_10474509 | |
| 0.025 | 0.076 | 0.036 | Retinoid X receptor antagonist | 0.036 0.03 CID_3036172 | CID_3036172 | |
| 0.137 | 0.19 | 0.189 | Streptokinase A inhibitor | 0.189 0.14 CID_10090750 | CID_10090750 | |
| 0.034 | 0.094 | 0.053 | Alpha-mannosidase inhibitor | 0.053 0.038 CID_10474509 | CID_10474509 | |
| 0.049 | 0.109 | 0.069 | Glutamate dehydrogenase inhibitor | 0.069 0.058 CID_3036172 0.068 0.059 CID_10474509 | CID_3036172 | |
| 0.094 | 0.157 | 0.183 | Phospholipase A2 inhibitor | 0.183 0.052 CID_3036172 | CID_3036172 | |
| 0.12 | 0.184 | 0.172 | Phospholipase C inhibitor | 0.172 0.07 CID_3036172 0.145 0.116 CID_10090750 | CID_3036172 | |
| 0.044 | 0.11 | 0.07 | Aminopeptidase I inhibitor | 0.07 0.054 CID_3036172 0.064 0.061 CID_10474509 | CID_3036172 | |
| 0.074 | 0.141 | 0.103 | Adenylate kinase inhibitor | 0.103 0.063 CID_3036172 0.092 0.082 CID_10474509 | CID_3036172 | |
| 0.132 | 0.202 | 0.168 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.168 0.11 CID_3036172 0.155 0.137 CID_10090750 | CID_3036172 | |
| 0.023 | 0.094 | 0.042 | Mannosidase inhibitor | 0.042 0.036 CID_10474509 | CID_10474509 | |
| 0.069 | 0.14 | 0.118 | Carbonic anhydrase XV inhibitor | 0.118 0.048 CID_3036172 | CID_3036172 | |
| 0.027 | 0.099 | 0.059 | Opioid delta receptor antagonist | 0.059 0.047 CID_10090750 | CID_10090750 | |
| 0.04 | 0.114 | 0.085 | Na+ K+ transporting ATPase inhibitor | 0.085 0.046 CID_3036172 | CID_3036172 | |
| 0.08 | 0.158 | 0.118 | Cathepsin H inhibitor | 0.118 0.078 CID_3036172 | CID_3036172 | |
| 0.016 | 0.095 | 0.042 | Vascular adhesion protein 1 inhibitor | 0.042 0.023 CID_3036172 | CID_3036172 | |
| 0.139 | 0.218 | 0.212 | Lipoxygenase inhibitor | 0.183 0.159 CID_3036172 0.212 0.128 CID_10090750 | CID_10090750 | |
| 0.051 | 0.134 | 0.116 | Aminopeptidase B inhibitor | 0.116 0.055 CID_3036172 | CID_3036172 | |
| 0.066 | 0.149 | 0.102 | Nav1.1 sodium channel blocker | 0.102 0.063 CID_10474509 | CID_10474509 | |
| 0.014 | 0.098 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 CID_3036172 | CID_3036172 | |
| 0.059 | 0.143 | 0.099 | UDP-glucose 4-epimerase inhibitor | 0.099 0.062 CID_10474509 | CID_10474509 | |
| 0.026 | 0.113 | 0.158 | Alcohol oxidase inhibitor | 0.158 0.009 CID_3036172 | CID_3036172 | |
| 0.031 | 0.119 | 0.049 | Parathyroid hormone antagonist | 0.049 0.024 CID_3036172 | CID_3036172 | |
| 0.019 | 0.108 | 0.052 | Ornithine carbamoyltransferase inhibitor | 0.052 0.037 CID_3036172 | CID_3036172 | |
| 0.095 | 0.184 | 0.117 | Papain-like protease (SARS coronavirus) inhibitor | 0.117 0.09 CID_10090750 | CID_10090750 | |
| 0.056 | 0.15 | 0.085 | Triose-phosphate isomerase inhibitor | 0.085 0.067 CID_3036172 0.085 0.067 CID_10474509 | CID_10474509 | |
| 0.063 | 0.157 | 0.103 | MAP kinase kinase 1 inhibitor | 0.103 0.053 CID_10474509 | CID_10474509 | |
| 0.047 | 0.141 | 0.076 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.076 0.046 CID_3036172 | CID_3036172 | |
| 0.06 | 0.155 | 0.09 | Carbonic anhydrase III inhibitor | 0.09 0.075 CID_3036172 | CID_3036172 | |
| 0.11 | 0.206 | 0.135 | ATPase inhibitor | 0.135 0.131 CID_10474509 | CID_10474509 | |
| 0.126 | 0.223 | 0.197 | Hypoglycemic | 0.197 0.115 CID_3036172 0.174 0.142 CID_10090750 0.169 0.149 CID_10474509 | CID_3036172 | |
| 0.122 | 0.219 | 0.201 | Cardiotonic | 0.201 0.118 CID_10474509 | CID_10474509 | |
| 0.047 | 0.147 | 0.08 | Opioid antagonist | 0.08 0.068 CID_10090750 | CID_10090750 | |
| 0.048 | 0.149 | 0.092 | Keratolytic | 0.092 0.036 CID_3036172 | CID_3036172 | |
| 0.096 | 0.198 | 0.129 | Melanin inhibitor | 0.129 0.116 CID_10090750 | CID_10090750 | |
| 0.062 | 0.165 | 0.234 | Tubulin antagonist | 0.234 0.028 CID_10474509 | CID_10474509 | |
| 0.053 | 0.159 | 0.077 | GABA B receptor agonist | 0.077 0.047 CID_3036172 | CID_3036172 | |
| 0.103 | 0.211 | 0.184 | Interleukin agonist | 0.184 0.135 CID_3036172 0.179 0.14 CID_10474509 | CID_3036172 | |
| 0.053 | 0.161 | 0.106 | Topoisomerase II inhibitor | 0.106 0.08 CID_10090750 | CID_10090750 | |
| 0.013 | 0.123 | 0.032 | HMG CoA reductase inhibitor | 0.032 0.029 CID_10474509 | CID_10474509 | |
| 0.097 | 0.212 | 0.135 | Sphingosine 1-phosphate receptor 5 antagonist | 0.135 0.09 CID_3036172 | CID_3036172 | |
| 0.066 | 0.185 | 0.23 | Thrombolytic | 0.23 0.039 CID_3036172 | CID_3036172 | |
| 0.073 | 0.193 | 0.154 | Peroxidase inhibitor | 0.154 0.076 CID_3036172 0.122 0.098 CID_10090750 | CID_3036172 | |
| 0.052 | 0.175 | 0.137 | GABA C receptor agonist | 0.137 0.039 CID_3036172 | CID_3036172 | |
| 0.03 | 0.169 | 0.081 | Glutamate decarboxylase inhibitor | 0.081 0.043 CID_3036172 | CID_3036172 | |
| 0.041 | 0.188 | 0.065 | Glutamate (mGluR6) antagonist | 0.065 0.052 CID_3036172 | CID_3036172 | |
| 0.153 | 0.314 | 0.188 | MAP kinase kinase 3 inhibitor | 0.188 0.16 CID_3036172 | CID_3036172 | |
| 0.076 | 0.253 | 0.379 | Interleukin antagonist | 0.379 0.034 CID_3036172 0.202 0.083 CID_10474509 | CID_3036172 | |
| 0.113 | 0.291 | 0.184 | Transcription factor STAT3 inhibitor | 0.184 0.158 CID_3036172 | CID_3036172 | |
| 0.037 | 0.224 | 0.074 | Glycine receptor agonist | 0.074 0.047 CID_3036172 | CID_3036172 | |
| 0.023 | 0.212 | 0.072 | Porphobilinogen synthase inhibitor | 0.072 0.054 CID_3036172 | CID_3036172 | |
| 0.075 | 0.266 | 0.162 | Growth hormone agonist | 0.162 0.078 CID_3036172 | CID_3036172 | |
| 0.111 | 0.43 | 0.229 | Interleukin 2 agonist | 0.229 0.144 CID_3036172 | CID_3036172 | |
| 0.035 | 0.456 | 0.372 | Antimitotic | 0.372 0.028 CID_10474509 | CID_10474509 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |